{"id":"W4405374515","doi":"10.1016/j.iotech.2024.100846","title":"103P Tislelizumab combined with chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: A multicenter, prospective, single-arm, real-world study","year":2024,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Esophageal squamous cell carcinoma; Medicine; Chemoradiotherapy; Oncology; Basal cell; Multicenter study; Internal medicine; Carcinoma; Radiation therapy; Randomized controlled trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000250672,0.000549728,0.001168913,0.0009652112,0.0002315292,0.00004861141,0.0004017676,0.0003753493,0.0001376611],"category_scores_gemma":[0.0000666898,0.000433639,0.0001773684,0.001213048,0.0005407872,0.0001305988,0.0001408567,0.0007974249,0.00004699334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002587087,"about_ca_system_score_gemma":0.001024273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002000387,"about_ca_topic_score_gemma":0.001066032,"domain_scores_codex":[0.9967908,0.00009589785,0.000578442,0.001127411,0.0003554136,0.001052063],"domain_scores_gemma":[0.9980689,0.0003417185,0.0001512909,0.0008940083,0.000353808,0.00019029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1410411,0.08129874,0.3927483,0.002537004,0.003880693,0.04629888,0.005213611,0.0000499052,0.07024034,0.004928799,0.003965833,0.2477968],"study_design_scores_gemma":[0.1941916,0.5061646,0.04333467,0.0003235662,0.001535122,0.00142534,0.003389489,0.001250678,0.23366,0.001621031,0.01175862,0.001345257],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.960015,0.02079327,0.0005894751,0.00320083,0.0005201948,0.01006139,0.00004949019,0.001313261,0.003457103],"genre_scores_gemma":[0.9867777,0.0001330419,0.004927418,0.000150801,0.0001097801,0.00401407,0.00005846992,0.0001524345,0.003676338],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4248658,"threshold_uncertainty_score":0.9998115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01325214264849089,"score_gpt":0.3187447232035502,"score_spread":0.3054925805550593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}